| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Poisoning by meprobamate |
Causative agent (attribute) |
True |
Meprobamate (substance) |
Inferred relationship |
Some |
1 |
| Accidental meprobamate poisoning |
Causative agent (attribute) |
False |
Meprobamate (substance) |
Inferred relationship |
Some |
|
| Intentional meprobamate poisoning (disorder) |
Causative agent (attribute) |
False |
Meprobamate (substance) |
Inferred relationship |
Some |
|
| intoxication par le méprobamate d'intention indéterminée |
Causative agent (attribute) |
False |
Meprobamate (substance) |
Inferred relationship |
Some |
1 |
| Meprobamate adverse reaction |
Causative agent (attribute) |
True |
Meprobamate (substance) |
Inferred relationship |
Some |
1 |
| Allergy to meprobamate |
Causative agent (attribute) |
False |
Meprobamate (substance) |
Inferred relationship |
Some |
|
| Meprobamate overdose (disorder) |
Causative agent (attribute) |
True |
Meprobamate (substance) |
Inferred relationship |
Some |
1 |
| Accidental meprobamate overdose |
Causative agent (attribute) |
True |
Meprobamate (substance) |
Inferred relationship |
Some |
1 |
| Intentional meprobamate overdose |
Causative agent (attribute) |
True |
Meprobamate (substance) |
Inferred relationship |
Some |
1 |
| surdose de méprobamate d'intention indéterminée |
Causative agent (attribute) |
False |
Meprobamate (substance) |
Inferred relationship |
Some |
1 |
| Meprobamate 400 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Meprobamate (substance) |
Inferred relationship |
Some |
|
| Meprobamate 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Meprobamate (substance) |
Inferred relationship |
Some |
|
| Meprobamate measurement |
Component |
True |
Meprobamate (substance) |
Inferred relationship |
Some |
1 |
| Product containing meprobamate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Meprobamate (substance) |
Inferred relationship |
Some |
1 |
| Meprobamate measurement, urine |
Component |
False |
Meprobamate (substance) |
Inferred relationship |
Some |
2 |
| Aspirin 325 mg and meprobamate 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Meprobamate (substance) |
Inferred relationship |
Some |
|
| Product containing aspirin and meprobamate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Meprobamate (substance) |
Inferred relationship |
Some |
1 |
| Intentional meprobamate poisoning (disorder) |
Causative agent (attribute) |
True |
Meprobamate (substance) |
Inferred relationship |
Some |
1 |
| Accidental poisoning by meprobamate |
Causative agent (attribute) |
True |
Meprobamate (substance) |
Inferred relationship |
Some |
1 |
| Allergy to meprobamate |
Causative agent (attribute) |
True |
Meprobamate (substance) |
Inferred relationship |
Some |
1 |
| Meprobamate 400 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Meprobamate (substance) |
Inferred relationship |
Some |
1 |
| Meprobamate 400 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Meprobamate (substance) |
Inferred relationship |
Some |
1 |
| Aspirin 325 mg and meprobamate 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Meprobamate (substance) |
Inferred relationship |
Some |
1 |
| Aspirin 325 mg and meprobamate 200 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Meprobamate (substance) |
Inferred relationship |
Some |
1 |
| Meprobamate 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Meprobamate (substance) |
Inferred relationship |
Some |
1 |
| Meprobamate 200 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Meprobamate (substance) |
Inferred relationship |
Some |
1 |
| Aspirin 325 mg and meprobamate 200 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Meprobamate (substance) |
Inferred relationship |
Some |
1 |
| Meprobamate 400 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Meprobamate (substance) |
Inferred relationship |
Some |
1 |
| Aspirin- and meprobamate-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Meprobamate (substance) |
Inferred relationship |
Some |
1 |
| Meprobamate 200 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Meprobamate (substance) |
Inferred relationship |
Some |
1 |
| Product containing meprobamate in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Meprobamate (substance) |
Inferred relationship |
Some |
1 |
| Product containing only aspirin and meprobamate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Meprobamate (substance) |
Inferred relationship |
Some |
1 |
| Product containing only meprobamate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Meprobamate (substance) |
Inferred relationship |
Some |
1 |
| Product containing only meprobamate in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Meprobamate (substance) |
Inferred relationship |
Some |
1 |
| Product containing only aspirin and meprobamate in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Meprobamate (substance) |
Inferred relationship |
Some |
1 |
| Meprobamate measurement, urine |
Component |
True |
Meprobamate (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]